Paul Herrling is the head of corporate research at Novartis and the chairman of board of the Novartis Institute for Tropical Diseases, Singapore[1] since 2002.[2] Prior to this, he was the head of Global Research of Novartis Pharma.

Paul Herrling is also Professor of Drug Discovery Science at the University of Basel, Switzerland and Full Adjunct Professor at the Harold Dorris Neurobiological Institute, Scripps Research Institute, La Jolla, California.

He obtained his Ph.D. in 1975 at the University of Zurich and was a post-doctorate fellow at the UCLA Neuropsychiatric Institute.

References

  1. ↑ "ESG".
  2. ↑ "Herrling English". Archived from the original on 2008-12-05. Retrieved 2009-01-12.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.